Avastin may lose metastatic breast cancer indication
An U.S. Food and Drug Administration (FDA)-advisory panel has voted to strip Avastin’s indication for metastatic breast cancer because the…
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.